These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25377371)

  • 1. Catatonic stupor secondary to gamma-hydroxy-butyric acid (GHB)-dependence and -withdrawal syndrome.
    Claussen MC; Hassanpour K; Jenewein J; Boettger S
    Psychiatr Danub; 2014 Dec; 26(4):358-9. PubMed ID: 25377371
    [No Abstract]   [Full Text] [Related]  

  • 2. Stupor in a catatonic patient due to an interaction between high-dose lorazepam and valproic acid: a case report.
    de Neeling M; van Paesschen W
    Acta Neurol Belg; 2021 Aug; 121(4):1077-1078. PubMed ID: 34296394
    [No Abstract]   [Full Text] [Related]  

  • 3. The Effect of Co-occurring Substance Use on Gamma-hydroxybutyric Acid Withdrawal Syndrome.
    Kamal RM; Dijkstra BA; Loonen AJ; De Jong CA
    J Addict Med; 2016; 10(4):229-35. PubMed ID: 27310146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines.
    Quang LS; Colombo G; Lobina C; Maccioni P; Orru A; Gessa GL; Maher TJ; Carai MA
    Ann N Y Acad Sci; 2006 Aug; 1074():545-58. PubMed ID: 17105952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration.
    Addolorato G; Caputo F; Capristo E; Bernardi M; Stefanini GF; Gasbarrini G
    Clin Neuropharmacol; 1999; 22(1):60-2. PubMed ID: 10047936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-hydroxybutyric acid (GHB) withdrawal: a case report.
    Bennett WR; Wilson LG; Roy-Byrne PP
    J Psychoactive Drugs; 2007 Sep; 39(3):293-6. PubMed ID: 18159783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged withdrawal from extreme gamma-hydroxybutyrate (GHB) abuse.
    Mahr G; Bishop CL; Orringer DJ
    Psychosomatics; 2001; 42(5):439-40. PubMed ID: 11739915
    [No Abstract]   [Full Text] [Related]  

  • 8. Catatonia associated with glutethimide withdrawal.
    Campbell R; Schaffer CB; Tupin J
    J Clin Psychiatry; 1983 Jan; 44(1):32-3. PubMed ID: 6822484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine withdrawal catatonia or lethal catatonia in a schizoaffective patient with a family history of Parkinson's disease.
    Thanasan S; Jambunathan ST
    Afr J Psychiatry (Johannesbg); 2010 Nov; 13(5):402, 404. PubMed ID: 21390412
    [No Abstract]   [Full Text] [Related]  

  • 10. Catatonia and alcohol withdrawal: a complex and underestimated syndrome.
    Geoffroy PA; Rolland B; Cottencin O
    Alcohol Alcohol; 2012; 47(3):288-90. PubMed ID: 22278315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ictal catatonia as a manifestation of de novo absence status epilepticus following benzodiazepine withdrawal.
    Kanemoto K; Miyamoto T; Abe R
    Seizure; 1999 Sep; 8(6):364-6. PubMed ID: 10512781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study.
    Caputo F; Francini S; Stoppo M; Lorenzini F; Vignoli T; Del Re A; Comaschi C; Leggio L; Addolorato G; Zoli G; Bernardi M
    J Psychopharmacol; 2009 Nov; 23(8):883-90. PubMed ID: 18635689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epileptic seizures superimposed on catatonic stupor.
    Suzuki K; Miura N; Awata S; Ebina Y; Takano T; Honda T; Shindo T; Matsuoka H
    Epilepsia; 2006 Apr; 47(4):793-8. PubMed ID: 16650147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catatonic stupor during the course of Parkinson's disease resolved with electroconvulsive therapy.
    Suzuki K; Awata S; Nakagawa K; Takano T; Matsuoka H
    Mov Disord; 2006 Jan; 21(1):123-4. PubMed ID: 16250024
    [No Abstract]   [Full Text] [Related]  

  • 15. [Severe hypernatremia within the scope of catatonic schizophrenia].
    Trabert W; von Blohn G; Gawlitza M
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):196-8. PubMed ID: 2873092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disulfiram encephalopathy as a cause of the catatonia syndrome.
    Weddington WW; Marks RC; Verghese JP
    Am J Psychiatry; 1980 Oct; 137(10):1217-9. PubMed ID: 7416268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study.
    Elsing C; Stremmel W; Grenda U; Herrmann T
    Am J Drug Alcohol Abuse; 2009; 35(3):189-92. PubMed ID: 19462303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats.
    Carai MA; Quang LS; Atzeri S; Lobina C; Maccioni P; Orrù A; Gessa GL; Maher TJ; Colombo G
    Brain Res Brain Res Protoc; 2005 Jul; 15(2):75-8. PubMed ID: 15886053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catatonic reaction to accidental haloperidol overdose: an unrecognized drug abuse risk.
    Hoffman AS; Schwartz HI; Novick RM
    J Nerv Ment Dis; 1986 Jul; 174(7):428-30. PubMed ID: 3723129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential diagnosis of acute life threatening catatonia and malignant neuroleptic syndrome--a case report].
    Hermle L; Oepen G
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):189-95. PubMed ID: 2873091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.